Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline

Int J Obes Relat Metab Disord. 1992 Dec:16 Suppl 3:S43-50.

Abstract

This progress report on the anorectic effect of serotoninergic indirect antagonists compares the action of D-fenfluramine, fluoxetine and sertraline and their N-dealkylated metabolites. Brain levels of drugs and their metabolites were measured after equi-active anorectic doses. Fluoxetine and sertraline inhibit 5-HT uptake in vitro with a potency which is at least one order of magnitude higher than for D-fenfluramine while all three drugs release 5-HT from synaptosomes and the active concentrations are closer to the brain concentrations reached after anorectic doses. However, a number of differences have been observed between D-fenfluramine and fluoxetine regarding the mechanisms of 5-HT release. Furthermore fluoxetine affected storage of 5-HT in vesicles much more than D-fenfluramine did. The anorectic effect induced by fluoxetine was not antagonized by antiserotoninergic drugs. No evidence of an involvement of CCK in the anorectic effect of D-fenfluramine was found when food intake was determined in rats previously submitted to food deprivation.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • 1-Naphthylamine / analogs & derivatives*
  • 1-Naphthylamine / pharmacokinetics
  • 1-Naphthylamine / pharmacology
  • Animals
  • Appetite Depressants / pharmacokinetics
  • Appetite Depressants / pharmacology*
  • Brain / drug effects
  • Brain / metabolism
  • Eating / drug effects
  • Fenfluramine / pharmacokinetics
  • Fenfluramine / pharmacology*
  • Fluoxetine / pharmacokinetics
  • Fluoxetine / pharmacology*
  • Humans
  • Serotonin / physiology
  • Serotonin Antagonists / pharmacology
  • Sertraline

Substances

  • Appetite Depressants
  • Serotonin Antagonists
  • Fluoxetine
  • Fenfluramine
  • Serotonin
  • 1-Naphthylamine
  • Sertraline